Dendreon

From Wikipedia, the free encyclopedia

Dendreon is a Seattle based biotechnology company. According to the company's web site, its leading product candidate, Provenge, is an immunotherapy for prostate cancer. The company has built manufacturing facilities in Hanover, New Jersey and hired 25 people there[1].

[edit] References

  1. ^ Seattle Times, August 9, 2006

[edit] External links